Franklin Resources’s Amedisys AMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-3,534
Closed -$321K 2966
2024
Q4
$321K Sell
3,534
-415
-11% -$38.1K ﹤0.01% 2480
2024
Q3
$382K Sell
3,949
-107
-3% -$10.4K ﹤0.01% 2396
2024
Q2
$372K Buy
+4,056
New +$376K ﹤0.01% 2352
2022
Q2
Sell
-1,170
Closed -$201K 2360
2022
Q1
$201K Buy
+1,170
New +$175K ﹤0.01% 2157
2021
Q4
Sell
-1,422
Closed -$212K 2472
2021
Q3
$212K Buy
1,422
+509
+56% +$106K ﹤0.01% 2218
2021
Q2
$224K Buy
+913
New +$240K ﹤0.01% 1821
2020
Q2
Sell
-1,157
Closed -$212K 1678
2020
Q1
$212K Sell
1,157
-251
-18% -$44.7K ﹤0.01% 1415
2019
Q4
$235K Buy
+1,408
New +$209K ﹤0.01% 1463

Other funds holding AMED

Franklin Resources's AMED Position: Q1 2025 in Review

Franklin Resources sold out of Amedisys (AMED) in Q1 2025, closing a stake of 3,534 shares — an estimated $321K sold.

Franklin Resources first reported a position in AMED in Q4 2019 and held it in 8 quarters. The position peaked at $382K in Q3 2024. 304 funds tracked by Wall St. Rank hold AMED as of Q1 2025.

  • Franklin Resources reported no remaining Amedisys position as of Q1 2025 after selling out during the quarter.
  • Franklin Resources sold 3,534 Amedisys shares in Q1 2025, an estimated $321K.
  • Franklin Resources first reported a position in Amedisys in Q4 2019 and held it in 8 quarters.
  • Franklin Resources's Amedisys position peaked at $382K in Q3 2024.
  • 304 funds tracked by Wall St. Rank held Amedisys as of Q1 2025.

Based on Franklin Resources's 13F filing for Q1 2025, filed 13 May 2025.